| Authors: | Serge Auger, Jean Lacoursière, and Pierre Picard |
|---|---|
| Themes: | High-Throughput, hair, Luxon-MS/MS |
Since the hair root is vascularized during its growth, illicit drugs present in the blood stream may enter the hair shaft via the root where they will be sequestered. Therefore, the use of illicit drugs can be revealed by analyzing a small hair sample. To increase the analysis throughput of hair samples, the Luxon Ion Source® coupled to tandem mass spectrometry (MS/MS) was used for the identification and quantification of drugs of abuse.
Our goal for this application note is to use an automated sample preparation method for the screen of drugs in hair sample using a single operation in LUXON-MS/MS.
LUXON-MS/MS offers specificity combined with an ultra-fast analysis for an unrivaled screening method. To develop this application, we focused on performing a quick and simple sample preparation. Drugs are analyzed simultaneously with quantitative screening results obtained in less than 9 seconds per sample.
The Luxon Ion Source® (Figure 1) is the second-generation sample introduction and ionization source based on the LDTD® technology for mass spectrometry. Luxon Ion Source® uses Fiber-Coupled Laser Diode (Figure 2) to obtain unmatchable thermal uniformity providing more precision, accuracy and speed. The process begins with dry samples which are rapidly evaporated using indirect heat. The thermally desorbed neutral molecules are carried into a corona discharge region. High efficiency protonation and strong resistance to ionic suppression characterize this type of ionization and is the result of the absence of solvent and mobile phase. This thermal desorption process yields high-intensity molecular ion signal in less than 1 second sample-to-sample and allows working with very small volumes.

Figure 1 – Luxon Ion Source®

Figure 2 – Schematic of the Luxon Ionization Source

Figure 3 – Automated extraction system
Model: Luxon SH-960, Phytronix
Carrier gas: 6 L/min (air with 20 µL/min water)
Laser pattern:
MS model: LC-8060, Shimadzu
Ionization: APCI
| Drugs | Transition | CE |
|---|---|---|
| Amphetamine (AMP) | 136 → 119 | 15 |
| Amphetamine-D 5 | 141 → 96 | 15 |
| Methamphetamine (MET) | 150 → 119 | 15 |
| Methamphetamine-D 9 | 159 → 125 | 15 |
| MDA | 180 → 133 | 20 |
| MDA-D 5 | 185 → 138 | 20 |
| MDMA | 194 → 163 | 10 |
| MDMA-D 5 | 199 → 165 | 10 |
| MDEA | 208 → 163 | 12 |
| Diethylpropion (DEP) | 206 → 100 | 25 |
| Diethylpropion-D 10 | 216 → 110 | 25 |
| PCP | 244 → 159 | 15 |
| PCP-D 5 | 249 → 164 | 15 |
| Mazindol (MAZ) | 285 → 242 | 20 |
| Mazindol-D 4 | 289 → 242 | 20 |
| Morphine (MOR) | 286 → 152 | 50 |
| Morphine-D 6 | 292 → 152 | 50 |
| Codeine (COD) | 300 → 152 | 50 |
| Codeine-D 6 | 306 → 152 | 50 |
| Cocaine (COC) | 304 → 182 | 20 |
| Cocaine-D 3 | 307 → 185 | 20 |
| 6-Monoacetylmorphine (6-MAM) | 328 → 165 | 35 |
| 6-Monoacetylmorphine-D 6 | 334 → 165 | 35 |
| Drugs | Transition | CE |
|---|---|---|
| THC | 313 → 245 | -30 |
| THC-D 3 | 316 → 248 | -30 |
Table 3 shows the suggested screening cut-offs currently used in the industry.
| Analyte | Cut-off |
|---|---|
| Amphetamine | 200 pg/mg Hair |
| Methamphetamine | 200 pg/mg Hair |
| MDA | 200 pg/mg Hair |
| MDMA | 200 pg/mg Hair |
| MDEA | 200 pg/mg Hair |
| Morphine | 200 pg/mg Hair |
| PCP | 200 pg/mg Hair |
| Cocaine | 250 pg/mg Hair |
| Codeine | 200 pg/mg Hair |
| 6-MAM | 200 pg/mg Hair |
| Diethylpropion | 200 pg/mg Hair |
| Mazindol | 200 pg/mg Hair |
| THC | 50 pg/mg Hair |
Figure 4 shows a typical desorption peak for a blank sample for Cocaine and Figure 5 shows a typical desorption peak for a cut-off sample for Cocaine. Similar results were obtained for the other drugs.

Figure 4 – Desorption peak of blank sample for Cocaine

Figure 5 – Desorption peak of cut-off sample for Cocaine
Spiked samples around the decision point and blank solutions are used to validate the precision of the method. The peak area against the internal standard (IS) ratio was used to normalize the signal. Replicate extractions are deposited on a LazWell™ plate and dried before analysis.
The following acceptance criteria were used:
Table 4 shows the precision results at the cut-off level.
| Amphetamine | Methamphetamine | ||
|---|---|---|---|
| Conc (pg/mg) | 200 | Conc (pg/mg) | 200 |
| N | 6 | N | 6 |
| Mean | 186.7 | Mean | 223.7 |
| %CV | 18.4 | %CV | 17.7 |
| MDA | MDMA | ||
| Conc (pg/mg) | 200 | Conc (pg/mg) | 200 |
| N | 6 | N | 6 |
| Mean | 194.5 | Mean | 222.9 |
| %CV | 19.4 | %CV | 16.9 |
| Diethylpropion | MDEA | ||
| Conc (pg/mg) | 200 | Conc (pg/mg) | 200 |
| N | 6 | N | 6 |
| Mean | 181.1 | Mean | 215.1 |
| %CV | 17.8 | %CV | 14.4 |
| PCP | Mazindol | ||
| Conc (pg/mg) | 200 | Conc (pg/mg) | 200 |
| N | 6 | N | 6 |
| Mean | 217.2 | Mean | 228.8 |
| %CV | 14.7 | %CV | 14.9 |
| Morphine | Codeine | ||
| Conc (pg/mg) | 200 | Conc (pg/mg) | 200 |
| N | 6 | N | 6 |
| Mean | 204.5 | Mean | 216.0 |
| %CV | 15.8 | %CV | 7.9 |
| Cocaine | 6-Monoacetylmorphine | ||
| Conc (pg/mg) | 250 | Conc (pg/mg) | 200 |
| N | 6 | N | 6 |
| Mean | 263.8 | Mean | 218.2 |
| %CV | 4.8 | %CV | 16.4 |
| THC | |||
| Conc (pg/mg) | 50 | ||
| N | 6 | ||
| Mean | 57.0 | ||
| %CV | 7.2 | ||
Luxon Ion Source® combined to a Shimadzu LC-8060 mass spectrometer system allows ultra-fast (9 seconds per sample) screening of drugs in hair using a simple and automated sample preparation method.